{"id":410349,"date":"2021-01-07T08:33:11","date_gmt":"2021-01-07T13:33:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=410349"},"modified":"2021-01-07T08:33:11","modified_gmt":"2021-01-07T13:33:11","slug":"albireo-to-host-virtual-investor-commercial-day-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/","title":{"rendered":"Albireo to Host Virtual Investor Commercial Day 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BOSTON, Jan.  07, 2021  (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a virtual Commercial Day for investors on February 11 from 11:30-1:00pm EST.<\/p>\n<p>Presentations will include an overview of the long-term corporate strategy, the global market opportunity in rare pediatric and adult liver disease, and the global commercialization strategy and launch readiness plans for odevixibat in progressive familial intrahepatic cholestasis (PFIC), an ultra-rare pediatric cholestatic liver disease.<\/p>\n<p>The event will be hosted by Ron Cooper, President and Chief Executive Officer and members of Albireo leadership.<\/p>\n<p>\n        <strong><br \/>\n          <u>Commercial Day Call Details for Thursday, February 11 from 11:30-1:00pm EST<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>\n        <strong>Domestic:<\/strong> 1-877-407-0792<br \/><strong>International<\/strong>: 1-201-689-8263<br \/><strong>Conference ID:<\/strong> 13714756<br \/><strong>Participant Webcast Link: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RiAiNak21vj90PlOQOfMEDvp7dWIllUioDU7X6XkMW3tyrCRwnfVZAxyHICbpQ_5ds-ACxlcdGB8B98x3WXal0j_9QCwvgzpJgEtpMk39RiFXU0ohqq42qkv2OL6A2-5FLki2dpQrylOLjA0sxJ58w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/public.viavid.com\/index.php?id=142919<\/a><\/p>\n<p>The virtual event will also be accessible from the Albireo Media and Investors page <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lyeJFF0QkNSvG1vsMp5BPs6MLcm_PkB1FcqRjmCKywBRByzTaCctM3vKT6w4JKVtGQnSbEhPJTx5BAPoa-CaCQ18OgRBvyLVxM-LAIs36nw=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir.albireopharma.com<\/a>.<\/p>\n<p>\n        <strong>About Albireo<\/strong><br \/>\n        <br \/>Albireo Pharma\u00a0is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo\u2019s lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca\u00a0in 2008 and is headquartered in\u00a0Boston,\u00a0Massachusetts, with its key operating subsidiary in\u00a0Gothenburg,\u00a0Sweden. The\u00a0Boston Business Journal\u00a0named Albireo one of the 2020 Best Places to Work in\u00a0Massachusetts for the second consecutive year. For more information on Albireo, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l6id6Wt4IVN9LBmySvYok79FwYct-tF_sYRW7VNyeo06C0dbnn4zg3KV5Ie1m9osVfqwvIKNKhN4LHGnvhfn0emVavYG-NSQcnMZIuFNbKEeVJa6qUIX51AYKDo_fawapg-jrWsLFNm-QqWTXdId7fJX7jCM5OQKIlQ4HFhmqPAY-IJ0xb0O5LqgYztKDuW2hHqf4SgOxTCSx7bzmmHSBY6riApBZgO34rYQtf8LC8HMC0_8FkMFj7-PJOF4G6gQFpj6A0XIgzwoRdqfjlq5k3pmFaXQ0ck6nmMEEcSYGqDHYU6qZSZjyxM96ZaVtOnvqMVwIhxfTQIeRFcCknFfeJZlAWmVVjH32u2wtv2IX8Yxf_0qMBw-qeWJuztYkVhKvevFtZ8fVbHpENvu-9IkXCdrDX9zP8ki76xjEeq5vvZQDBGvJYvoB7Qcz4vmcx3yBbJ3evL8rRxPWCPbgYEGMbYTPMBun_SGQ0pdIhT9guQ=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.albireopharma.com<\/a>.<\/p>\n<p>\n        <strong>Media &amp; Investor contacts:<\/strong><br \/>\n        <br \/>Colleen Alabiso, 857-356-3905, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dg6malb760QJdDjKqH5C-_52hePMSGU17eJoIEapQQ5EDTGPgBHoZSkRSp45dcrk3tbVwP2plQw4_qUBxFhZ7JH7xiZ0bem3LvzSCNXA0eE53ION7gsZBKhUhScK57tp\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">colleen.alabiso@albireopharma.com<\/a><br \/>Hans Vitzthum, LifeSci Advisors, LLC., 617-430-7578<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/4bbc6137-6e7d-4f71-b185-c45a8e90014d\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON, Jan. 07, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a virtual Commercial Day for investors on February 11 from 11:30-1:00pm EST. Presentations will include an overview of the long-term corporate strategy, the global market opportunity in rare pediatric and adult liver disease, and the global commercialization strategy and launch readiness plans for odevixibat in progressive familial intrahepatic cholestasis (PFIC), an ultra-rare pediatric cholestatic liver disease. The event will be hosted by Ron Cooper, President and Chief Executive Officer and members of Albireo leadership. Commercial Day Call Details for Thursday, February 11 from 11:30-1:00pm EST Domestic: 1-877-407-0792International: 1-201-689-8263Conference ID: 13714756Participant Webcast &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Albireo to Host Virtual Investor Commercial Day 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-410349","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Albireo to Host Virtual Investor Commercial Day 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Albireo to Host Virtual Investor Commercial Day 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON, Jan. 07, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a virtual Commercial Day for investors on February 11 from 11:30-1:00pm EST. Presentations will include an overview of the long-term corporate strategy, the global market opportunity in rare pediatric and adult liver disease, and the global commercialization strategy and launch readiness plans for odevixibat in progressive familial intrahepatic cholestasis (PFIC), an ultra-rare pediatric cholestatic liver disease. The event will be hosted by Ron Cooper, President and Chief Executive Officer and members of Albireo leadership. Commercial Day Call Details for Thursday, February 11 from 11:30-1:00pm EST Domestic: 1-877-407-0792International: 1-201-689-8263Conference ID: 13714756Participant Webcast &hellip; Continue reading &quot;Albireo to Host Virtual Investor Commercial Day 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T13:33:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Albireo to Host Virtual Investor Commercial Day 2021\",\"datePublished\":\"2021-01-07T13:33:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/\"},\"wordCount\":307,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/\",\"name\":\"Albireo to Host Virtual Investor Commercial Day 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=\",\"datePublished\":\"2021-01-07T13:33:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-host-virtual-investor-commercial-day-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Albireo to Host Virtual Investor Commercial Day 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Albireo to Host Virtual Investor Commercial Day 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/","og_locale":"en_US","og_type":"article","og_title":"Albireo to Host Virtual Investor Commercial Day 2021 - Market Newsdesk","og_description":"BOSTON, Jan. 07, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a virtual Commercial Day for investors on February 11 from 11:30-1:00pm EST. Presentations will include an overview of the long-term corporate strategy, the global market opportunity in rare pediatric and adult liver disease, and the global commercialization strategy and launch readiness plans for odevixibat in progressive familial intrahepatic cholestasis (PFIC), an ultra-rare pediatric cholestatic liver disease. The event will be hosted by Ron Cooper, President and Chief Executive Officer and members of Albireo leadership. Commercial Day Call Details for Thursday, February 11 from 11:30-1:00pm EST Domestic: 1-877-407-0792International: 1-201-689-8263Conference ID: 13714756Participant Webcast &hellip; Continue reading \"Albireo to Host Virtual Investor Commercial Day 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-07T13:33:11+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Albireo to Host Virtual Investor Commercial Day 2021","datePublished":"2021-01-07T13:33:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/"},"wordCount":307,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/","name":"Albireo to Host Virtual Investor Commercial Day 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=","datePublished":"2021-01-07T13:33:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTk1MiMzOTA4Mjk2IzIwODA2NTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-host-virtual-investor-commercial-day-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Albireo to Host Virtual Investor Commercial Day 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=410349"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410349\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=410349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=410349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=410349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}